PharmSource Coverage of ASCO 2017
Chicago hosted 30,000 American Society of Clinical Oncology (ASCO) conference visitors this weekend, including myself and fellow researcher Scotty Chung-Siu. You may have noticed the uptick in the PharmSource Lead Sheet recently, especially in Phase I & II studies. In fact, oncology leads hold 46% of this week’s PharmSource Lead Sheet, so be sure to check it out to find more information, including development phases, APIs, specific therapeutic areas if available, enrollment status, FDA & EMA designations, and much more.
Let us know if you’d like to see more about any upcoming conferences, or need help navigating through PharmSource tools. We always look forward to the opportunity to help you make the most out of your PharmSource subscription!